PRO MEDICUS LIMITED — Director's Dealing 2024

Dec 3, 2024

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Anthony Barry HALL
Date of last notice	13 September 2024

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Ordinary fully paid shares in Pro Medicus Limited held by Anthony Hall
Date of change	04 December 2024
No. of securities held prior to change	25,144,000 ordinary shares consisting off:-  24,200,000 ordinary shares held under Anthony Barry HALL  867,500 ordinary shares held under Akay Superannuation Fund  41,500 ordinary shares held under Research Corporation Pty Ltd as trustee for the Anthony Hall Family Trust  35,000 ordinary shares held by Anthony Hall ATF Anthony Hall Testamentary Trust

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

==> picture [434 x 407] intentionally omitted <==

----- Start of picture text -----

Class Ordinary shares
Number acquired Nil
Number disposed 1,000,000 ordinary shares
Value/Consideration $256.73 per share
Note: If consideration is non-cash, provide details and estimated valuation
No. of securities held after change 24,144,000 ordinary shares consisting off:-
 23,200,000 ordinary shares held
under Anthony Barry HALL
 867,500 ordinary shares held under
Akay Superannuation Fund
 41,500 ordinary shares held under
Research Corporation Pty Ltd as
trustee for the Anthony Hall Family
Trust
 35,000 ordinary shares held by
Anthony Hall ATF Anthony Hall
Testamentary Trust.
Nature of change On market trade
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back
----- End of picture text -----

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

For and on behalf of Pro Medicus Limited

==> picture [141 x 64] intentionally omitted <==

Danny English Company Secretary 04 December 2024

• See chapter 19 for defined terms.

Appendix 3Y Page 3